vTv Therapeutics Statistics Share Statistics vTv Therapeutics has 2.62M
shares outstanding. The number of shares has increased by 0.19%
in one year.
Shares Outstanding 2.62M Shares Change (YoY) 0.19% Shares Change (QoQ) 0% Owned by Institutions (%) 8.91% Shares Floating 1.49M Failed to Deliver (FTD) Shares 7 FTD / Avg. Volume 0.22%
Short Selling Information The latest short interest is 17.09K, so 0.65% of the outstanding
shares have been sold short.
Short Interest 17.09K Short % of Shares Out 0.65% Short % of Float 1.54% Short Ratio (days to cover) 3.15
Valuation Ratios The PE ratio is -4.32 and the forward
PE ratio is -6.27.
vTv Therapeutics's PEG ratio is
0.06.
PE Ratio -4.32 Forward PE -6.27 PS Ratio 78.37 Forward PS 219.1 PB Ratio 6.53 P/FCF Ratio -3.15 PEG Ratio 0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for vTv Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 7.34,
with a Debt / Equity ratio of 0.01.
Current Ratio 7.34 Quick Ratio 7.34 Debt / Equity 0.01 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $44.22K Profits Per Employee $-802.7K Employee Count 23 Asset Turnover 0.03 Inventory Turnover n/a
Taxes Income Tax 100K Effective Tax Rate -0.44%
Stock Price Statistics The stock price has increased by 65.18% in the
last 52 weeks. The beta is 0.67, so vTv Therapeutics's
price volatility has been higher than the market average.
Beta 0.67 52-Week Price Change 65.18% 50-Day Moving Average 18.01 200-Day Moving Average 17.37 Relative Strength Index (RSI) 73.38 Average Volume (20 Days) 3,244
Income Statement In the last 12 months, vTv Therapeutics had revenue of 1.02M
and earned -18.46M
in profits. Earnings per share was -3.2.
Revenue 1.02M Gross Profit 928K Operating Income -24.18M Net Income -18.46M EBITDA -22.52M EBIT -22.61M Earnings Per Share (EPS) -3.2
Full Income Statement Balance Sheet The company has 36.75M in cash and 169K in
debt, giving a net cash position of 36.58M.
Cash & Cash Equivalents 36.75M Total Debt 169K Net Cash 36.58M Retained Earnings -299.72M Total Assets 26.45M Working Capital 21.08M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -25.31M
and capital expenditures 0, giving a free cash flow of -25.31M.
Operating Cash Flow -25.31M Capital Expenditures n/a Free Cash Flow -25.31M FCF Per Share -4.39
Full Cash Flow Statement Margins Gross margin is 91.25%, with operating and profit margins of -2377.58% and -1815.34%.
Gross Margin 91.25% Operating Margin -2377.58% Pretax Margin -2222.71% Profit Margin -1815.34% EBITDA Margin -2213.96% EBIT Margin -2377.58% FCF Margin -2488.4%
Dividends & Yields VTVT does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for VTVT is $35.5,
which is 47.3% higher than the current price. The consensus rating is "Buy".
Price Target $35.5 Price Target Difference 47.3% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Nov 21, 2023. It was a
backward
split with a ratio of 1:40.
Last Split Date Nov 21, 2023 Split Type backward Split Ratio 1:40
Scores Altman Z-Score -16.99 Piotroski F-Score 0
